Login
Israel-Hamas Conflict
Independence Day
Social Media
Formula 1
Motorsports
Drones
Donald Trump
Wrestling
Infrastructure
Natural Disasters
World Cup
Immigration
Property
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

Summary by The Bakersfield Californian
PARIS--(BUSINESS WIRE)--Jul 2, 2025-

4 Articles

All
Left
Center
2
Right
1
The Bakersfield CalifornianThe Bakersfield Californian
+2 Reposted by 2 other sources
Center

Ferring ADAPT-1 Trial Builds on Dosing Evidence for Follitropin Delta

PARIS--(BUSINESS WIRE)--Jul 2, 2025-

·Bakersfield, United States
Read Full Article
pharmafile.compharmafile.com

Ferring strengthens evidence for flexible dosing of follitropin delta in IVF - Pharmafile

Ferring Pharmaceuticals has reported that a conventional 15µg/day starting dose of follitropin delta (Rekovelle) provides comparable efficacy and safety to a standard 225IU/day dose of follitropin alfa in women undergoing ovarian stimulation for fertility treatments: in vitro fertilisation or intracytoplasmic sperm injection. This reinforces the clinical evidence base for follitropin delta, the only recombinant follicle-stimulating […] The post …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Bakersfield Californian broke the news in Bakersfield, United States on Wednesday, July 2, 2025.
Sources are mostly out of (0)

Similar News Topics

Paris, France icon

Paris, France

News
For You
SearchBlindspotLocal